Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$479M |
| 2 |
Meta Platforms (Facebook)
META
|
+$465M |
| 3 |
State Street Consumer Discretionary Select Sector SPDR ETF
XLY
|
+$445M |
| 4 |
Kenvue
KVUE
|
+$434M |
| 5 |
Micron Technology
MU
|
+$431M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$3.24B |
| 2 |
Apple
AAPL
|
+$1.9B |
| 3 |
Microsoft
MSFT
|
+$1.56B |
| 4 |
PepsiCo
PEP
|
+$1.34B |
| 5 |
JPMorgan Chase
JPM
|
+$1.34B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.7% |
| 2 | Financials | 7.47% |
| 3 | Consumer Discretionary | 6.7% |
| 4 | Communication Services | 6.02% |
| 5 | Healthcare | 4.93% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
401
Norfolk Southern
NSC
$75.1B
| $128M | 0.03% |
444,677
+55,060
| +14% | +$15.9M |
|
402
PUT
Freeport-McMoran
FCX
$97.5B
| $127M | 0.03% |
2,504,600
+1,603,800
| +178% | +$69.5M |
|
403
Royal Caribbean
RCL
$85.6B
| $126M | 0.03% |
453,391
-219,021
| -33% | -$61.9M |
|
|
GLIBK
404
Liberty Capital Corp Series C GCI Group Common Stock
GLIBK
$958M
| $126M | 0.03% |
3,386,430
+168,113
| +5% | +$5.9M |
|
405
PUT
XPO
XPO
$23.7B
| $126M | 0.03% |
927,000
+810,000
| +692% | +$110M |
|
406
First Solar
FSLR
$26.9B
| $126M | 0.03% |
481,334
-93,499
| -16% | -$23.6M |
|
407
CBRE Group
CBRE
$42.9B
| $126M | 0.03% |
781,833
+40,445
| +5% | +$6.36M |
|
408
Arch Capital
ACGL
$33.6B
| $126M | 0.03% |
1,309,600
-189,063
| -13% | -$17.3M |
|
409
eBay
EBAY
$49.8B
| $125M | 0.03% |
1,440,677
-806,625
| -36% | -$69.8M |
|
410
PUT
Bristol-Myers Squibb
BMY
$132B
| $125M | 0.03% |
2,322,000
+2,009,900
| +644% | +$96.7M |
|
411
Corning
GLW
$143B
| $125M | 0.03% |
1,428,753
-205,609
| -13% | -$17.7M |
|
412
Kinder Morgan
KMI
$68.7B
| $125M | 0.03% |
4,547,216
+396,626
| +10% | +$10.7M |
|
413
EOG Resources
EOG
$70.7B
| $125M | 0.03% |
1,188,272
+72,874
| +7% | +$7.83M |
|
|
SW
414
Smurfit Westrock
SW
$25.3B
| $124M | 0.03% |
3,202,649
-2,067,094
| -39% | -$78.8M |
|
415
Realty Income
O
$59.1B
| $123M | 0.03% |
2,190,863
-550,903
| -20% | -$31.9M |
|
416
Coca-Cola Europacific Partners
CCEP
$47.9B
| $123M | 0.03% |
1,359,039
+347,245
| +34% | +$31.4M |
|
417
CALL
SoFi Technologies
SOFI
$23.7B
| $123M | 0.03% |
4,700,000
| – | – |
|
418
CALL
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
$32.8B
| $122M | 0.03% |
1,107,300
-1,919,800
| -63% | -$213M |
|
419
PUT
Goldman Sachs
GS
$303B
| $122M | 0.03% |
138,700
-12,000
| -8% | -$9.79M |
|
420
Akamai
AKAM
$15.9B
| $121M | 0.03% |
1,390,780
+541,781
| +64% | +$44.6M |
|
421
PUT
Starbucks
SBUX
$120B
| $121M | 0.03% |
1,440,100
+1,229,300
| +583% | +$104M |
|
422
PUT
Morgan Stanley
MS
$340B
| $121M | 0.03% |
681,800
+25,400
| +4% | +$4.24M |
|
423
PUT
Carnival Corporation Ltd
CCL
$39.7B
| $121M | 0.03% |
3,962,900
+854,800
| +28% | +$23.8M |
|
424
Nasdaq
NDAQ
$52.9B
| $121M | 0.03% |
1,245,999
-1,198,040
| -49% | -$108M |
|
425
Southwest Airlines
LUV
$23B
| $120M | 0.03% |
2,905,923
+601,892
| +26% | +$21M |
|
Similar funds
Barclays's Q4 2025 Portfolio in Review
As of Q4 2025, Barclays held 5,847 positions worth $417B, down 9.7% from $461B the previous quarter. Its ten largest holdings account for 35% of the portfolio.
Barclays withdrew a net $49.1B in Q4 2025, closing 641 positions and reducing 1,715 holdings. Its most notable exit was Verona Pharma, an estimated $149M position sold in full.
By sector, the portfolio is most concentrated in Technology at 20% of assets, down from 20% a quarter earlier, followed by Financials and Consumer Discretionary.
Against the trend, Barclays opened a new position in The Magnum Ice Cream Company N.V. worth $156M.
- Barclays's largest Q4 2025 buy was The Magnum Ice Cream Company N.V.: 9,862,859 shares worth $156M.
- Barclays added most to Gilead Sciences in Q4 2025, an estimated $479M increase.
- Barclays's biggest Q4 2025 reduction was NVIDIA, cutting an estimated $3.24B.
- Barclays fully exited Verona Pharma in Q4 2025, selling an estimated $149M.
- Barclays's ten largest holdings make up 35% of its $417B portfolio in Q4 2025.
- Barclays opened 403 new positions and closed 641 in Q4 2025.
- Barclays's portfolio value fell 9.7% quarter-over-quarter to $417B.
Based on Barclays's 13F filing for Q4 2025, filed 13 Feb 2026.